Literature DB >> 24480807

Fibulin-3 suppresses Wnt/β-catenin signaling and lung cancer invasion.

Xiaojun Chen1, Jie Meng2, Wen Yue3, Jian Yu3, Jie Yang2, Zhi Yao4, Lin Zhang3.   

Abstract

The 5 year survival rate of lung cancer is <20%, with most patients dying from distant metastasis. However, the molecular mechanisms underlying lung cancer invasion and metastasis have not been fully characterized. In this study, we found that fibulin-3, a fibulin family extracellular matrix protein, functions as a suppressor of lung cancer invasion and metastasis. Fibulin-3 was downregulated in large fractions of lung tumors and cell lines, and inhibited lung cancer cell invasion and the expression of matrix metalloproteinase-7 (MMP-7), a promoter of lung cancer invasion. The expression levels of fibulin-3 and MMP-7 were inversely correlated in lung tumors. Fibulin-3 inhibited extracellular signal-regulated kinase (ERK) to activate glycogen synthase kinase 3β and suppress Wnt/β-catenin signaling, which induces MMP-7 expression in lung cancer cells. Furthermore, fibulin-3 expression impeded the growth and metastasis of lung tumors in mice. Collectively, these results suggest that downregulation of fibulin-3 contributes to lung cancer invasion and metastasis by activating Wnt/β-catenin signaling and MMP-7 expression.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24480807      PMCID: PMC4123641          DOI: 10.1093/carcin/bgu023

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  44 in total

Review 1.  New functions for the matrix metalloproteinases in cancer progression.

Authors:  Mikala Egeblad; Zena Werb
Journal:  Nat Rev Cancer       Date:  2002-03       Impact factor: 60.716

Review 2.  Matrix metalloproteinases: a tail of a frog that became a prince.

Authors:  Constance E Brinckerhoff; Lynn M Matrisian
Journal:  Nat Rev Mol Cell Biol       Date:  2002-03       Impact factor: 94.444

3.  gamma-Catenin expression is reduced or absent in a subset of human lung cancers and re-expression inhibits transformed cell growth.

Authors:  Robert A Winn; Roy M Bremnes; Lynne Bemis; Wilbur A Franklin; York E Miller; Carlyne Cool; Lynn E Heasley
Journal:  Oncogene       Date:  2002-10-24       Impact factor: 9.867

Review 4.  Focus on lung cancer.

Authors:  John D Minna; Jack A Roth; Adi F Gazdar
Journal:  Cancer Cell       Date:  2002-02       Impact factor: 31.743

Review 5.  Metastasis suppressors alter the signal transduction of cancer cells.

Authors:  Patricia S Steeg
Journal:  Nat Rev Cancer       Date:  2003-01       Impact factor: 60.716

6.  The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors.

Authors:  H C Crawford; B M Fingleton; L A Rudolph-Owen; K J Goss; B Rubinfeld; P Polakis; L M Matrisian
Journal:  Oncogene       Date:  1999-05-06       Impact factor: 9.867

7.  Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin.

Authors:  Qingqing Ding; Weiya Xia; Jaw-Ching Liu; Jer-Yen Yang; Dung-Fang Lee; Jiahong Xia; Geoffrey Bartholomeusz; Yan Li; Yong Pan; Zheng Li; Ralf C Bargou; Jun Qin; Chien-Chen Lai; Fuu-Jen Tsai; Chang-Hai Tsai; Mien-Chie Hung
Journal:  Mol Cell       Date:  2005-07-22       Impact factor: 17.970

8.  Identification of c-MYC as a target of the APC pathway.

Authors:  T C He; A B Sparks; C Rago; H Hermeking; L Zawel; L T da Costa; P J Morin; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

9.  Overexpression of WISP-1 down-regulated motility and invasion of lung cancer cells through inhibition of Rac activation.

Authors:  Lilian L Soon; Ting-An Yie; Anita Shvarts; Arnold J Levine; Fei Su; Kam-Meng Tchou-Wong
Journal:  J Biol Chem       Date:  2003-01-15       Impact factor: 5.157

10.  Exploring TCGA Pan-Cancer data at the UCSC Cancer Genomics Browser.

Authors:  Melissa S Cline; Brian Craft; Teresa Swatloski; Mary Goldman; Singer Ma; David Haussler; Jingchun Zhu
Journal:  Sci Rep       Date:  2013-10-02       Impact factor: 4.379

View more
  32 in total

1.  Fibulin-3 promotes muscle-invasive bladder cancer.

Authors:  A L Han; B A Veeneman; L El-Sawy; K C Day; M L Day; S A Tomlins; E T Keller
Journal:  Oncogene       Date:  2017-05-15       Impact factor: 9.867

2.  TGIF1 promoted the growth and migration of cancer cells in nonsmall cell lung cancer.

Authors:  Guo Xiang; Yang Yi; He Weiwei; Wu Weiming
Journal:  Tumour Biol       Date:  2015-06-24

3.  p38 MAPK down-regulates fibulin 3 expression through methylation of gene regulatory sequences: role in migration and invasion.

Authors:  María Arechederra; Neibla Priego; Ana Vázquez-Carballo; Celia Sequera; Álvaro Gutiérrez-Uzquiza; María Isabel Cerezo-Guisado; Sara Ortiz-Rivero; Cesáreo Roncero; Ana Cuenda; Carmen Guerrero; Almudena Porras
Journal:  J Biol Chem       Date:  2014-12-29       Impact factor: 5.157

4.  Fibulin-3 Deficiency Protects Against Myocardial Injury Following Ischaemia/ Reperfusion in in vitro Cardiac Spheroids.

Authors:  Poonam Sharma; Dominik Beck; Lucy A Murtha; Gemma Figtree; Andrew Boyle; Carmine Gentile
Journal:  Front Cardiovasc Med       Date:  2022-06-20

5.  Curcumin suppresses proliferation and invasion in non-small cell lung cancer by modulation of MTA1-mediated Wnt/β-catenin pathway.

Authors:  Yimin Lu; Changjiang Wei; Zhaoqing Xi
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-06-18       Impact factor: 2.416

6.  Epidermal growth factor-containing fibulin-like extracellular matrix protein 1 expression and regulation in uterine leiomyoma.

Authors:  Erica E Marsh; Shani Chibber; Ju Wu; Kendra Siegersma; Julie Kim; Serdar Bulun
Journal:  Fertil Steril       Date:  2015-12-17       Impact factor: 7.329

7.  Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.

Authors:  H Tian; J Liu; J Chen; M L Gatza; G C Blobe
Journal:  Oncogene       Date:  2015-03-30       Impact factor: 9.867

8.  Fibulin-5 inhibits Wnt/β-catenin signaling in lung cancer.

Authors:  Xiaojun Chen; Xiaomeng Song; Wen Yue; Dongshi Chen; Jian Yu; Zhi Yao; Lin Zhang
Journal:  Oncotarget       Date:  2015-06-20

Review 9.  Oncogenomic portals for the visualization and analysis of genome-wide cancer data.

Authors:  Katarzyna Klonowska; Karol Czubak; Marzena Wojciechowska; Luiza Handschuh; Agnieszka Zmienko; Marek Figlerowicz; Hanna Dams-Kozlowska; Piotr Kozlowski
Journal:  Oncotarget       Date:  2016-01-05

10.  Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis.

Authors:  Michaela B Kirschner; Emily Pulford; Mir Alireza Hoda; Anita Rozsas; Kim Griggs; Yuen Yee Cheng; J James B Edelman; Steven C Kao; Rebecca Hyland; Yawen Dong; Viktoria László; Thomas Klikovits; Michael P Vallely; Michael Grusch; Balazs Hegedus; Balazs Dome; Walter Klepetko; Nico van Zandwijk; Sonja Klebe; Glen Reid
Journal:  Br J Cancer       Date:  2015-08-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.